期刊文献+

NT-proBNP联合galectin-3对慢性心力衰竭患者预后的评估价值 被引量:11

Prognostic value of combination of N-terminal B-type brain natriuretic peptide and galectin-3 in patients with chronic heart failure
原文传递
导出
摘要 目的 评价N端B型脑钠肽前体(NT-proBNP)联合半乳糖凝集素3(galectin-3)对慢性心力衰竭(CHF)患者预后的价值.方法 测定92例CHF患者入院和出院时血NT-proBNP和galectin-3水平,观察、随访出院后16个月内因心力衰竭再发住院率及死亡率.结果 美国纽约心脏病协会(NYHA)心功能Ⅰ、Ⅱ、Ⅲ、Ⅳ级患者NT-proBNP水平分别为(351.6±467.5)pg/ml、(493.2±411.7) pg/ml、(1 289.6±737.8) pg/ml、(2719.2±1 044.1)pg/ml;galectin-3水平分别为(12.23±6.12) ng/ml、(13.59±5.46) ng/ml、(21.18±7.44) ng/ml、(26.61±8.82) ng/mlo NT-proBNP和galec-tin-3的水平随患者心功能的降低而升高.出院时NT-proBNP或galectin-3仍高于正常的患者在随访中发生心力衰竭再发住院或死亡的几率明显高于正常的患者;而出院时NT-proBNP和galectin-3均增高的患者其预后明显较其中一项值增高的患者差.结论 NT-proBNP和galectin-3两者均是心力衰竭患者不良预后的独立预测指标,galectin-3联合NT-proBNP可以更好地评估CHF患者的预后. Objective To evaluate prognostic value of N-terminal B-type brain natriuretic peptide (NT-proBNP) combined with galectin 3 of prognostic value in patients with chronic heart failure (CHF).Methods Determination of 92 cases of CHF patients on admission and at discharge plasma NT-proBNP and galectin-3 levels,then after the patients discharge we follow up 16 months and observe the internal recurrent heart failure hospitalization rate and mortality.Results In patients the heart function of New York Heart Association (NYHA) Ⅰ,Ⅱ,Ⅲ,Ⅳ level,NT-proBNP were (351.6 ± 467.5) pg/ml,(493.2 ± 411.7) pg/ml,(1 289.6 ± 737.8) pg/ml,(2 719.2 ± 1 044.1) pg/ml,galectin-3 (12.23 ± 6.12) ng/ml,(13.59± 5.46) ng/ml,(19.18 ± 7.44) ng/ml,(26.61 ± 8.82) ng/ml as well.NT-proBNP and galectin-3 levels were increased with the depression of cardiac function.The patients who had higher NT-proBNP or galectin3 levels discharged and occurred the more probability of re-hospitalization on account of heart failure or death.Compared to those patients with one of them increased,the patients whose discharge NT-proBNP and galectin-3 value were both increased with significantly poor outcome.Conclusions Both NT-proBNP and galectin-3 were independent predictors of poor prognosis in patients with heart failure.Galectin-3 combined with NT-proBNP can assess the prognosis of patients with CHF more effectively.
出处 《中国医师杂志》 CAS 2015年第9期1347-1350,共4页 Journal of Chinese Physician
基金 湖南省人民医院仁术基金资助项目(201012)
关键词 利钠肽 脑/投药和剂量 半乳糖凝集素3/投药和剂量 心力衰竭/药物疗法 Natriuretic peptide,brain/AD Galectin 3/AD Heart failure/DT
  • 相关文献

参考文献16

  • 1Gupta S, Drazner MH, de Lemos JA. Newer biomarkers in heart failure [J]. Heart Fail Clin,2009 ,5(4) :579-588. 被引量:1
  • 2Masson S, Latini R. Amino-terminal pro-B-type natriuretic pep- tides and prognosis in chronic heart failure [ J ]. Am J Cardiol, 2008,101 (3A) :56-60. 被引量:1
  • 3Lok D J, Lok SI, Bruggink-Andr6 de la Porte PW, et al. Galectin- 3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure[ J]. Clin Res Cardiol, 2013, 102(2) :103-110. 被引量:1
  • 4李宇华..Galectin-3的亚细胞定位与结肠炎癌变的关系[D].第四军医大学,2007:
  • 5Funasaka T, Raz A, Nangia-Makker P. Nuclear transport of ga- lectin-5 and its therapeutic implications [ J ]. Semin Cancer Biol, 2014,27:30-58. 被引量:1
  • 6Suzuki O, Abe M. Recent progress and new perspectives in lym- phoma glycobiology [J]. Fukushima J Med Sci, 2013,59( 1 ):1- 14. 被引量:1
  • 7Francia P, Adduci C, Semprini L, et al. Osteopontin and galectin- 3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators [ J ]. J Cardiovasc Electrophysiol, 2014 ,25 (6) :609-616. 被引量:1
  • 8Ho JE, Yin X, Levy D,et al. Galectin 3 and incident atrial fibril-lation in the community[J]. An: Heart J, 2014 , 167 (5) : 729- 34. e1. 被引量:1
  • 9Hrynchyshyn N, Jourdain P, Desnos M,et al. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure [ J ]. Arch Cardiovasc Dis, 2013,106 (10) : 541-546. 被引量:1
  • 10De Boer RA, Yu L,van Veldhuisen DJ. Galectin-3 in Cardiac re- modeling and heart failure [ J ]. Curr Heart Fail Rep, 2010,7 (1) :1-8. 被引量:1

同被引文献95

引证文献11

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部